2011 Archived NewsDecember
One of the most fascinating bits of research in this area is being done by a group at Cornell University's Textiles Nanotechnology Laboratory. They've developed a means of actually making transistors out of cotton fibers to develop a type of organic electronics.
Blind mice could be a thing of the past thanks to a new prosthetic device that's been tested on the animals.
Cornell generates some 50 tons of hazardous waste a year across its 6,500 research spaces, 100 departments and 85 buildings. Keeping tabs on all those spaces and waste products used to be a logistical nightmare for Cornell's Environmental Health and Safety (EH&S) crew.
The Atlantic Philanthropies and its founding chairman, Chuck Feeney '56, were behind the $350 million gift -- initially announced as from an anonymous donor -- made in support of Cornell's New York City Tech Campus.
The donor whose $350 million gift will be critical in building Cornell University's new high-tech graduate school on Roosevelt Island is Atlantic Philanthropies, whose founder, Charles F. Feeney, is a Cornell alumnus who made billions of dollars through the Duty Free Shoppers Group.
Mayor Michael Bloomberg will announce Monday Cornell University the winner of a $100 million competition to build a state-of-the art engineering and applied science graduate school on Roosevelt Island, sources said.
Mayor Michael Bloomberg plans to announce on Monday that Cornell University won the high-profile competition to build a new applied-science campus in New York City.
Four Cornell faculty members have been elected fellows of the American Association for the Advancement of Science (AAAS), the world's largest general scientific society and publisher of the journal Science.
Cornell University announced an anonymous $350 million gift to support its bid for a proposed engineering campus in New York City hours after Stanford University said it was pulling out of the competition.
Cornell startup, e2e Materials, developer of biocomposite materials ramping up manufacturing capacity to meet growing demand from Fortune 100 customers
With high yields, good disease resistance, eye-appeal and a mild flavor with pineapple overtones, 'Herriot' is a sweet option for growers.
A tiny 3-D collagen 'scaffold' developed in a Cornell lab could prove a lifesaver for those who have lost parts of their intestine.
The product has potential in such markets as hospitals, pharmaceuticals, food services and other research-based organizations.
Research focuses on implementing radio frequency MEMS resonators on a silicon chip
New research reports on new method that reveals complete set of aberrant signaling pathways that give rise to cancers
Cornell startup, Metabolon, Inc., announced that they have received laboratory accreditation from the College of American Pathologists (CAP).
Researchers From Weill Cornell Medical College Report That the New Technique Is Greater Than 90 Percent Sensitive in Identifying Melanoma, the Deadliest Form of Skin Cancer
Weill Cornell researchers have established a new means of treating neuroendocrine prostate cancers, the most lethal subtype of the disease.
A high-tech stuffed robot dog is helping veterinary students at Cornell practice critical care procedures under nearly real-life conditions.
Researchers at Cornell tested participants' willingness to pay for different apple varieties using auctions.
Weill Cornell researchers have discovered a genetic Achilles' heel in an aggressive type of prostate cancer.
Using auctions, Cornell researchers tested participants' willingness to pay for different varieties of apples, including a patented variety developed at Cornell, currently named NY1.
Cornell researcher, Harold Craighead, and his colleagues review the future of graphene.
Cornell researcher, Tanzeem Choudhury, and his colleagues are working on cell phones that can monitor stress levels in speech.
Cornell inventor, Uli Wiesner, and his colleagues have created metamaterials with unusual optical properties.
Cornell inventor, Will Dichtel, will work on accurate design and synthesis of nanoribbons using controlled chemistry procedures.
Sheila Nirenberg of Weill Cornell Medical College presented her lab's success allowing blind mice to essentially see again at TEDMED.
Cornell inventor, Juan Hinestroza, was part of an international team that developed transistors using natural cotton fibers.
Weill Cornell Medical College researchers take an important step forward in their quest to 'turn on' lung regeneration
Cornell startup, Pacific Biosciences, reports Q3 revenues of $10.5M.
Cornell researchers are developing prototypes of multiphoton endoscopes that can be used in clinical settings to directly image tissues or tumors.
Cornell researchers are focusing on developing grapes with three attributes - fruit quality, cold hardiness, and resistance to powdery mildew.
Cornell startup, Metabolon, opens a new metabolics lab in Shanghai, China in collaboration with Shanghai Jiao Tong University (SJTU).
Cornell startup, Stealth Peptides, moves mitochondrial candidate into Phase II Trials.
John Alexander '74, MBA '76, a founder of the CBORD Group, Inc., has been named Cornell Entrepreneur of the Year 2012.
A team of Cornell researchers is exploring the computational aspects of how to manage the changing electrical grid.
Cornell breeder, Michael Mazourek, is engineering organic varieties in his lab and fields, using a combination of traditional and cutting-edge techniques.
Cornell researchers, along with UPenn scientists, have identified a gene responsible for a blindness-inducing disease that afflicts dogs.
Cornell professor, Courtney Weber, picked the first harvest of his newly-developed Crimson Giant Raspberry variety.
Cornell's new raspberry variety, Crimson Giant, can extend the harvest window for fresh, local raspberries to the beginning of November.
Cornell researcher, Margaret Bynoe, and her colleagues have found that when adenosine receptors are activated on cells that comprise the blood-brain barrier, a gateway into the blood-brain barrier can be established.
Cornell signed an agreement with Biotime to develop and commercialize technology developed at Weill Cornell Medical College.
Cornell apples, NY 1 and NY 2, are mentioned in an article about how breeders are creating odd, new hybrids.
Cornell developed variety, Flutterby Grande Peach Cobbler Nectar Bush, wins Best of Show at the 2011 Farwest Show.
Cornell researchers are tackling deceptive opinion spam.
Cornell Vice Provost, Alan Paau, emceed China Medical City event in New York City.
Noah Snavely, Assistant Professor of Computer Science, has been named one of Technology Review Magazine's, 'TR35', a top technology innovator under age 35.
Antibacterial clothing and anti-counterfeit devices are key pieces of research at Juan Hinestroza's Textiles Nanotechnology Laboratory.
Scientists at Weill Cornell Medical College have developed the means to tag RNA with fluorophores that allows the nucleic acid molecules to be tracked as they travel through living cells.
Cornell engineers create a biologically based spinal implant that could mean relief for sufferers.
Samie Jaffrey of Weill Cornell Medical College and his colleagues have found a way to reveal what's happening inside a cell by attaching a reflective tag to a chemical called RNA.
Cornell researchers have invented a tiny camera with no lenses or moving parts. It is made of 4,000 light sensors.
Alleged theft of proprietary Cornell apples reported.
CCTEC partners with Kirchner Food Security Group, a group that was formed to tackle the growing issues and pursuing global opportunities of global food security.
Cornell inventor Hod Lipson and his group develop a newly approved standard for 3-D printing file interchange that will greatly enhance 3-D printing capabilities.
Noah Snavely of Computer Science has been named a Microsoft Research Faculty Fellow for 2011.
Cornell scientists have developed a new and less painful method to end life-threatening heart fibrillations.
Cornell inventor Alyosha Molnar and his colleagues develop a microscopic device that fits on the head of a pin, contains no lenses or moving parts, and costs pennies to make.
Cornell researchers develop a lens-free camera that is 100th of a millimeter thick and one-half millimeter on each side.
Cornell researchers have shown that tissue grafts that promote vascular growth could hasten wound healing.
New York Apple Growers (NYAG) is planning for the managed release of new Cornell apples.
Cornell startup, MADathletic, is selling the football training device to university football programs, as well as, to high school and Pop warner teams.
Mayo Clinic is licensing a genotyping test for warfarin sensitivity in clinical and research settings from Cornell startup, Rheonix.
Cornell researcher, Bettina Wagner, and her colleagues have developed a new test for Lyme disease that exceeds its predecessors in accuracy, specificity, and analytical sensitivity.
WCMC-Q researcher Joel Malek and his colleagues have identified a region of the date palm genome linked to gender.
Cornell startup, ZetrOZ, introduces the first wearable, therapeutic ultrasound system for the equine market, the UltrOZ Elite Therapy System.
A recent report issued by the Intellectual Property Owners Association listed 14 universities, including Cornell, among the top 300 organizations to receive patents from the USPTO in 2010.
Cornell startup, Metabolon, expands beyond service offering and adds diagnostics to business.
Weill Cornell researcher, Sheila Nirenberg, wins $250,000 in the 2011 BioAccelerate competition.
The Johnson School has proven to be a great resource for CCTEC to tap into when searching for business people (see page 5).
Weill Cornell researchers have been able to overcome resistance of a form of leukemia to targeted therapy.
Cornell startup, New York Apple Growers (NYAG), is seeking partners to market their new varieties.
Alumnus Louis Walcer named first director of the McGovern Family Center for Venture Development in the Life Sciences.
A team of Cornell researchers is developing a portable, rapid and inexpensive test to detect rotavirus (a common cause of diarrhea), which would allow for the early intervention needed to save lives.
Paul McEuen, Dept. of Physics, and Carl Nathan, Dept. of Microbiology & Immunology, are elected to National Academy of Sciences.
Recent results from a test of an anticocaine vaccine in mice at Weill Cornell Medical College were encouraging.
C Dots were recently approved for clinical trials and are revolutionizing human optical capability.
Cornell researchers are printing vertebral tissue that tests well in mice and working on printing heart valves.
Hazel Szeto's research could lead to a new class of drugs to treat conditions ranging from heart attacks and strokes, to diabetes and neurodegenerative diseases.
Competing entrepreneurs demonstrated unprecedented passion and talent at annual event, and showcased what it takes to sell an idea in the 21st century economy.
Bred to thrive in Northeast growing conditions, organic farmers across the United States can now plant the hardy hybrid; one of the first licenses was granted to Iowa-based Blue River Hybrids, which distributes organic seeds nationwide.
Cornell University is releasing two brand new varieties of potatoes that have taken about 13 years to develop.
A new fabric that can selectively trap gases is being developed at Cornell, in a breakthrough that promises to help protect soldiers and first responders from exposure to toxic chemicals.
A new cloth that can selectively trap noxious gases and odors has been developed by Cornell researchers.
Cornell inventor William Dichtel and colleagues have found a way to synthesize ordered organic films that could be a major step toward improving the performance of organic solar cells.
Cornell researcher Brian Lazzaro argues that clues from insect immunity suggest that previous models may not be mutually exclusive and, in fact, may work in tandem to trigger appropriately calibrated immune responses.
Bariatric (weight loss) surgery has been shown to reduce the risk of heart attack and stroke in patients with diabetes in a study done by Weill Cornell Medical College researchers.
Industry collaborations among academic tech transfer offices rise as spinouts become more difficult in tepid VC/PE environment.
According to a Cornell inventor, a technology commonly used in human medicine would provide veterinarians with a quick, noninvasive alternative for diagnosing fungal keratitis in the equine eye.
Cornell inventor, Paul McEuen, publishes a fiction book about a Cornell professor trying to contain a deadly strain of fungus weaponized by the Japanese during WWII.
ADDF awards a grant of $170,750 to ADispell to develop small molecule drugs designed to halt the progression of cognition loss that occurs with Alzheimer's disease.
Since 1980 in particular, with the implementation of the Bayh-Dole Act, innovation has had a direct boost from the U.S. government by providing universities, small businesses and nonprofits with direct control of intellectual property resulting from federal funding.
Neurologix's (a Cornell licensee) gene therapy eased some Parkinson's disease symptoms in a mid-stage trial.
Cornell inventors Ehsan Afshari and Omeed Momeni, Electrical & Computer Engineering, design microchips that generate terahertz radiation for medical, dental, and security applications.
Prof. Frank Moon, Mechanical & Aerospace Engineering, developed a new method of harvesting wind energy that uses silent vibrational pads to transform wind-induced vibrations into electricity.
Researchers at Weill Cornell Medical College use a sophisticated imaging test to probe for higher-level cognitive functioning in severely brain-injured patients.
Cornell inventors have developed robots that can reflect their own thoughts rather than model their own bodies.
Cornell researchers have developed a printer that can print with biological materials to make 3D tissue constructs.
Cornell inventor John March and his research team have developed an artificial intestine that will allow scientists to grow cells under realistic physiological conditions.
Waneta and Lamoka are especially appealing to potato chip manufacturers because they fare well in storage and produce a nice color when cut.
PacBio and Novomer, both startups based on licensed Cornell technologies, are listed in Technology Review's 50 Most Innovative Companies of 2011.
Using whole genome sequencing and multiple tumor samples, Weill Cornell researchers uncover genes tied to prostate cancer growth.
Zipping ions down a MEMS racetrack could lead to portable particle beams.
Johannes Gehrke of the Computer Science Department has received an award to support a collaborative research project in Germany.
The U.S. Food and Drug Administration has approved the first clinical trial in humans of 'Cornell Dots'.
Five Cornell faculty receive NSF CAREER awards.
Cornell researchers are developing more effective ways to detect and prevent food-borne illness.
Boston Scientific Corporation has acquired Cornell startup, Intelect Medical, Inc., for $78M.
Cornell researchers, along with scientists at The Scripps Research Institute, have developed a vaccine that combines the common cold virus with a cocaine antigen to produce a long-lasting immunity to the stimulant effects of cocaine in mice.